Fulgent Genetics Debt 2024

Fulgent Genetics Aktienanalyse

What does Fulgent Genetics do?

Fulgent Genetics Inc. is a US company founded in 2011 by Jianxing (Justin) Liu and Ming Hsieh. The company has undergone remarkable development and is now active in the field of genomics and genetics. Fulgent Genetics' business model is based on the development and distribution of solutions for the diagnosis of genetic diseases. The company offers a variety of products and services that enable doctors, clinics, and laboratories to make effective diagnoses based on genetics. One of Fulgent Genetics' main divisions is the Clinical Diagnostics department, which offers a wide range of diagnostic products that allow for both molecular diagnoses and the creation of clinical profiles for patients. This enables doctors and clinics to quickly and accurately detect and treat specific diseases. Another important division of Fulgent Genetics is the Research department, which focuses on the discovery and development of new technologies and testing procedures. These technologies and procedures are of great interest to the scientific community and are used in research or clinical studies. Fulgent Genetics also offers a Pharmacogenomics department, which is a growing segment in the personalized medicine market. The goal here is to tailor medications to the patient's genetic makeup. Fulgent Genetics' technology allows for the analysis of a patient's current genetic makeup and recommends medications based on that. Another important area of Fulgent Genetics is the direct-to-consumer sales of tests. This is particularly significant in the field of ancestry and genealogy research. Fulgent Genetics offers a variety of tests in this area and has already achieved great success. Overall, Fulgent Genetics offers a wide range of products and services mainly focused on the diagnosis of genetic diseases. However, the company also goes beyond that and provides solutions for a wide range of customers and applications. Fulgent Genetics is based in the US and has experienced rapid growth since its founding. The company's success is also reflected in the many awards it has received. It has been recognized multiple times and has established a reputation as one of the leading biotechnology companies in the world. Fulgent Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Fulgent Genetics's Debt Structure

Fulgent Genetics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Fulgent Genetics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Fulgent Genetics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Fulgent Genetics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Fulgent Genetics Stock

What is the debt of Fulgent Genetics this year?

Fulgent Genetics has a debt level of -91.99 USD this year.

What was the debt of Fulgent Genetics compared to the previous year?

The debt of Fulgent Genetics has increased by 63.97% compared to the previous year increased.

What are the consequences of high debt for investors in Fulgent Genetics?

High debt can pose a risk for investors of Fulgent Genetics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Fulgent Genetics?

Low debt means that Fulgent Genetics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Fulgent Genetics affect the company?

An increase in debt of Fulgent Genetics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Fulgent Genetics affect the company?

A reduction in debt of Fulgent Genetics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Fulgent Genetics?

Some factors that can influence the debt of Fulgent Genetics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Fulgent Genetics so important for investors?

The debts of Fulgent Genetics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Fulgent Genetics take to change the debt?

To change the debt, Fulgent Genetics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Fulgent Genetics pay?

Over the past 12 months, Fulgent Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fulgent Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Fulgent Genetics?

The current dividend yield of Fulgent Genetics is .

When does Fulgent Genetics pay dividends?

Fulgent Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fulgent Genetics?

Fulgent Genetics paid dividends every year for the past 0 years.

What is the dividend of Fulgent Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fulgent Genetics located?

Fulgent Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fulgent Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fulgent Genetics from 6/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/9/2024.

When did Fulgent Genetics pay the last dividend?

The last dividend was paid out on 6/9/2024.

What was the dividend of Fulgent Genetics in the year 2023?

In the year 2023, Fulgent Genetics distributed 0 USD as dividends.

In which currency does Fulgent Genetics pay out the dividend?

The dividends of Fulgent Genetics are distributed in USD.